Drug Trial Radar · NCT07413939
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
650
Planned (sponsor's estimate)
Start
May 21, 2026
Primary completion
May 1, 2029
Study completion Sep 29, 2032
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Feb 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy and safety of RO7771950 in combination with trastuzumab and capecitabine, compared to tucatinib in combination with trastuzumab and capecitabine.
Conditions
- HER2-positive Breast Cancer
Interventions
RO7771950Drug
Participants will receive one of two doses of RO7771950 orally (PO) twice a day (BID).
TucatinibDrug
Participants will receive a dose of tucatinib PO BID.
TrastuzumabDrug
Participants will receive trastuzumab in accordance with local prescribing information, either through intravenous (IV) or subcutaneously (SC).
CapecitabineDrug
Participants will receive capecitabine according to local prescribing information. Capecitabine will be administered PO BID.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free Survival (PFS) as Determined by Blinded Independent Central Review (BICR)Time frame: Approximately 35 months
Locations
219 sites in 26 countries. Site status is shown where the registry gives one.
Clearview Cancer Institute
Huntsville, Alabama · Recruiting
Banner Health MD Anderson AZ
Gilbert, Arizona · Recruiting
Community Cancer Institute (CCI)
Clovis, California · Recruiting
UC Davis Comprehensive Cancer Center
Sacramento, California · Recruiting
UCSF Helen Diller Family CCC
San Francisco, California · Recruiting
Eastern Connecticut Hematology and Oncology Associates
Norwich, Connecticut · Recruiting
Cancer & Hematology Centers of Western Michigan
Grand Rapids, Michigan · Recruiting
Astera Cancer Care East Brunswick
East Brunswick, New Jersey · Recruiting
New York Oncology Hematology, P.C.
Albany, New York · Recruiting
New York Cancer and Blood Specialists
Shirley, New York · Recruiting
Stony Brook Univ Cancer Ctr
Stony Brook, New York · Recruiting
Montefiore Einstein Cancer Center
The Bronx, New York · Recruiting
The West Clinic, PC dba West Cancer Center
Germantown, Tennessee · Recruiting
Sarah Cannon Research Institute
Nashville, Tennessee · Recruiting
Tennessee Oncology Elliston Place Plaza
Nashville, Tennessee · Recruiting
Texas Oncology Cancer Center
Austin, Texas · Recruiting
The Center for Cancer and Blood Disorders - Fort Worth
Fort Worth, Texas · Recruiting
Centro Médico Fleischer
Buenos Aires, Argentina · Recruiting
Investigaciones Clínicas Moleculares
Buenos Aires, Argentina · Recruiting
Instituto Alexander Fleming
Buenos Aires, Argentina · Recruiting
Fundación Respirar
CABA, Argentina · Recruiting
Hospital Provincial del Centenario
Rosario, Argentina · Recruiting
Centro Oncológico de Excelencia
San Juan, Argentina · Recruiting
Blacktown Hospital
Blacktown, New South Wales, Australia · Recruiting
Macquarie University Hospital
Macquarie Park, New South Wales, Australia · Recruiting
Monash Health
Clayton, Victoria, Australia · Recruiting
Barwon Health
Geelong, Victoria, Australia · Recruiting
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia · Recruiting
Sunshine Hospital
St Albans, Victoria, Australia · Recruiting
Sir Charles Gairdner Hospital
Perth, Western Australia, Australia · Recruiting
Lkh-Univ. Klinikum Graz
Graz, Austria · Recruiting
Ordensklinikum Linz Barmherzige Schwestern
Linz, Austria · Recruiting
Lkh Salzburg - Univ. Klinikum Salzburg
Salzburg, Austria · Recruiting
Medizinische Universität Wien
Vienna, Austria · Recruiting
Institut Jules Bordet
Anderlecht, Belgium · Recruiting
Cliniques Universitaires St-Luc
Brussels, Belgium · Recruiting
Jessa Zkh (Campus Virga Jesse)
Hasselt, Belgium · Recruiting
AZ Groeninge
Kortrijk, Belgium · Recruiting
UZ Leuven Gasthuisberg
Leuven, Belgium · Recruiting
AZ St Maarten Campus Leopoldstr
Mechelen, Belgium · Recruiting
Showing 40 of 219 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.